What is the treatment for necrotizing fasciitis in pediatric patients with a penicillin allergy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

For pediatric patients with necrotizing fasciitis and a penicillin allergy, treatment should be initiated with clindamycin 40 mg/kg/day divided into 3-4 doses, not to exceed 2.7 grams per day, or linezolid 30 mg/kg/day divided into 2-3 doses, not to exceed 600 mg per dose, in combination with a broad-spectrum antibiotic that covers Gram-negative bacteria, such as piperacillin-tazobactam 1.

Key Considerations

  • The choice of antibiotic should be guided by the severity of the infection, the presence of any underlying medical conditions, and the potential for resistance to certain antibiotics.
  • Surgical debridement is essential in the treatment of necrotizing fasciitis, and should be performed as soon as possible after diagnosis 1.
  • Antimicrobial therapy should be administered until further debridement is no longer necessary, the patient has improved clinically, and fever has been resolved for 48–72 h 1.
  • Procalcitonin monitoring may be useful to guide antimicrobial discontinuation 1.

Treatment Duration

  • Treatment duration is typically 4-6 weeks, but may vary depending on the severity of the infection and clinical response.

Monitoring and Adjustment

  • It is essential to consult with a pediatric infectious disease specialist and closely monitor the patient's condition to adjust treatment as needed.
  • Culture-specific results and sensitivities can direct both broadening of antimicrobial regimen if it is too narrow 1.

From the FDA Drug Label

Clindamycin is indicated in the treatment of serious infections caused by susceptible anaerobic bacteria. Clindamycin is also indicated in the treatment of serious infections due to susceptible strains of streptococci, pneumococci, and staphylocci Its use should be reserved for penicillin-allergic patients or other patients for whom, in the judgment of the physician, a penicillin is inappropriate. Serious skin and soft tissue infections; To reduce the development of drug-resistant bacteria and maintain the effectiveness of clindamycin hydrochloride and other antibacterial drugs, clindamycin hydrochloride should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria

For pediatric patients with a penicillin allergy and necrotizing fasciitis, clindamycin may be considered as a treatment option, as it is indicated for serious skin and soft tissue infections, including those caused by susceptible strains of streptococci and staphylococci, which can cause necrotizing fasciitis 2.

  • The treatment should be guided by bacteriologic studies to determine the causative organisms and their susceptibility to clindamycin.
  • Local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy in the absence of culture and susceptibility data.

From the Research

Treatment for Necrotizing Fasciitis in Pediatric Patients with a Penicillin Allergy

  • The treatment for necrotizing fasciitis in pediatric patients typically involves early aggressive surgical treatment, as noted in the study by 3.
  • In cases where the patient has a penicillin allergy, alternative antibiotics such as clindamycin and metronidazole may be used, as suggested by 4.
  • The choice of antibiotic should be guided by the results of wound cultures and susceptibility testing, as noted in the study by 5.
  • Supportive care, including management of sepsis and wound care, is also an important part of the treatment, as highlighted in the case report by 6.
  • In some cases, surgical debridement and drainage of the affected fascial planes may be necessary, as reported in the study by 7.

Antibiotic Treatment Options

  • Clindamycin is a suitable alternative to penicillin for the treatment of necrotizing fasciitis, as it has been shown to be effective against the causative organisms, as noted in the study by 4.
  • Metronidazole may also be used in combination with other antibiotics, as suggested by 4.
  • The use of broad-spectrum antibiotics, such as ampicillin/sulbactam, may be necessary in some cases, as reported in the study by 4.

Surgical Management

  • Early aggressive surgical treatment is crucial in the management of necrotizing fasciitis, as noted in the study by 3.
  • Surgical debridement and drainage of the affected fascial planes may be necessary to remove infected tissue and promote healing, as reported in the study by 7.
  • In some cases, serial surgical debridement may be necessary to manage the extent of the infection, as highlighted in the case report by 6.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Diagnosis and Treatment of Pediatric Necrotizing Fasciitis: A Systematic Review of the Literature.

European journal of pediatric surgery : official journal of Austrian Association of Pediatric Surgery ... [et al] = Zeitschrift fur Kinderchirurgie, 2017

Research

Necrotizing fasciitis: treatment concepts and clinical results.

European journal of trauma and emergency surgery : official publication of the European Trauma Society, 2018

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.